SOD3 and metabolic dysfunction-associated steatotic liver disease: In line with these previous findings and our own adipose tissue SOD3 NAFLD DE and SOD3 knockdown results, we observed a significant downregulation of RNF128 in the SOD3 treated liver HepG2 cells when compared to the control cells.